The U.S. is stepping up its COVID-19 response with two major breakthroughs: the first over-the-counter rapid test 🌡️ and a potential second vaccine approval this week! The FDA greenlit a prescription-free at-home test that delivers results ASAP—no lab drop-off required. Meanwhile, Moderna’s vaccine candidate, shown to be 94% effective across diverse groups with mild side effects, could get the nod by Friday. 💪
Vaccine Rollout: Who Gets It First?
Up to 20 million Americans could get vaccinated by December’s end, with healthcare workers and long-term care residents prioritized. Major pharmacies like CVS and Walgreens are teaming up with the government for distribution. But hold tight, Gen Z—general availability might take a few more months. 😷
Reality Check: Cases Still Surging
While these advances are 🔥, hospitals remain overwhelmed as infections climb. Experts urge caution: masks on, parties off (for now). 🚨
Reference(s):
COVID-19: U.S. makes headway with vaccines & at-home testing
cgtn.com